Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For a benefits director, a popular thousand-dollar-a-month medication with an open-ended duration of use is one of the hardest line items in modern plan design
The list of FDA-approved indications for this class of medication has grown as of late (and currently includes type 2 diabetes, obesity, cardiovascular event risk reduction, obstructive sleep apnea, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease), and areas of interest for potential future indications are just as long and farreaching
Mounjaro is not currently licensed specifically for the treatment of hypertriglyceridaemia (elevated triglycerides), and it should not be prescribed solely for lipid management
Prevalence of carnitine depletion in critically ill patients with undernutrition
